These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28189653)

  • 1. Corrigendum to "Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice" [Toxicol. Appl. Pharmacol. 316 (2017) 74-82].
    Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
    Toxicol Appl Pharmacol; 2017 Apr; 320():73. PubMed ID: 28189653
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice.
    Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
    Toxicol Appl Pharmacol; 2017 Feb; 316():74-82. PubMed ID: 28038998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36.
    Momken I; Chabowski A; Dirkx E; Nabben M; Jain SS; McFarlan JT; Glatz JF; Luiken JJ; Bonen A
    Biochem J; 2017 Jan; 474(1):149-162. PubMed ID: 27827305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity" [Toxicol. Appl. Pharmacol. 321 (2017) 1-17].
    Fader KA; Nault R; Kirby MP; Markous G; Matthews J; Zacharewski TR
    Toxicol Appl Pharmacol; 2018 Apr; 344():74. PubMed ID: 29501526
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of AMPKα2 Is Not Required for Mitochondrial FAT/CD36 Accumulation during Exercise.
    Monaco C; Whitfield J; Jain SS; Spriet LL; Bonen A; Holloway GP
    PLoS One; 2015; 10(5):e0126122. PubMed ID: 25965390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36.
    Habets DD; Coumans WA; Voshol PJ; den Boer MA; Febbraio M; Bonen A; Glatz JF; Luiken JJ
    Biochem Biophys Res Commun; 2007 Mar; 355(1):204-10. PubMed ID: 17292863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats.
    Bonen A; Jain SS; Snook LA; Han XX; Yoshida Y; Buddo KH; Lally JS; Pask ED; Paglialunga S; Beaudoin MS; Glatz JF; Luiken JJ; Harasim E; Wright DC; Chabowski A; Holloway GP
    Diabetologia; 2015 Oct; 58(10):2381-91. PubMed ID: 26197708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
    Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary α-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs.
    Podszun MC; Grebenstein N; Spruss A; Schlueter T; Kremoser C; Bergheim I; Frank J
    J Nutr Biochem; 2014 May; 25(5):573-9. PubMed ID: 24725433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104].
    Ganapathy S; Li P; Fagman J; Yu T; Lafontant J; Zhang G; Chen C
    Toxicol Appl Pharmacol; 2017 Jan; 314():118. PubMed ID: 27851896
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.
    Choi YJ; Lee CH; Lee KY; Jung SH; Lee BH
    Toxicol Sci; 2015 Jun; 145(2):273-82. PubMed ID: 25745068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Differential effects of the persistent DDT metabolite methylsulfonyl-DDE in nonstimulated and LH-stimulated neonatal porcine Leydig cells" [Toxicol. Appl. Pharmacol. 267 (2013) 247-255].
    Castellanos CG; Sørvik IB; Tanum MB; Verhaegen S; Brandt I; Ropstad E
    Toxicol Appl Pharmacol; 2017 Oct; 332():159-160. PubMed ID: 28522354
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Use of a combined effect model approach for discriminating between ABCB1- and ABCC1-type efflux activities in native bivalve gill tissue" [Toxicol. Appl. Pharmacol. (2016) 56-67].
    Faria M; Pavlichenko V; Burkhardt-Medicke K; Soares AMVM; Altenburger R; Barata C; Luckenbach T
    Toxicol Appl Pharmacol; 2016 Jul; 303():110. PubMed ID: 27157384
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Immunotoxicity and biodistribution analysis of arsenic trioxide in C57B1/6 mice following a 2-week inhalation exposure": [Toxicol. Appl. Pharmacol. 241 (2009) 253-259].
    Burchiel SW; Mitchell LA; Lauer FT; Sun X; McDonald JD; Hudson LG; Liu KJ
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):188. PubMed ID: 21103386
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity Toxicol Appl Pharmacol, 354 (2018) 64-80.
    Delp J; Gutbier S; Cerff M; Zasada C; Niedenführ S; Zhao L; Smirnova L; Hartung T; Borlinghaus H; Schreiber F; Bergemann J; Gätgens J; Beyss M; Azzouzi S; Waldmann T; Kempa S; Nöh K; Leist M
    Toxicol Appl Pharmacol; 2019 Jun; 372():70. PubMed ID: 31002859
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to 'Embryotoxic and pharmacologic potency ranking of six azoles in the rat whole embryo culture by morphological and transcriptomic analysis' [Toxicol. Appl. Pharmacol., 322 (2017) 15-26].
    Dimopoulou M; Verhoef A; Pennings J; van Ravenzwaay B; Rietjens IMCM; Piersma AH
    Toxicol Appl Pharmacol; 2018 Sep; 355():287. PubMed ID: 29980297
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs" [Toxicol. Appl. Pharmacol., 284 (2015) 16-32].
    Poulsen SS; Saber AT; Williams A; Andersen O; Købler C; Atluri R; Pozzebon ME; Mucelli SP; Simion M; Rickerby D; Mortensen A; Jackson P; Kyjovska ZO; Mølhave K; Jacobsen NR; Jensen KA; Yauk CL; Wallin H; Halappanavar S; Vogel U
    Toxicol Appl Pharmacol; 2018 Sep; 355():286. PubMed ID: 29908758
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to 'Characterization of heme oxygenase and biliverdin reductase gene expression in zebrafish (Danio rerio): Basal expression and response to pro-oxidant exposures' [Toxicol. Appl. Pharmacol. 311 (2016) 74-87].
    Holowiecki A; O'Shields B; Jenny MJ
    Toxicol Appl Pharmacol; 2018 Oct; 356():98. PubMed ID: 30031761
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis "Toxicol Appl Pharmacol. 2016;305:194-202".
    Lin CF; Huang HL; Peng CY; Lee YC; Wang HP; Teng CM; Pan SL
    Toxicol Appl Pharmacol; 2020 Jan; 387():114858. PubMed ID: 31843362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.